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Abstract
Background: It has been argued that placebos may not have important clinical impacts in general. However, there is
increasing evidence of a publication bias among trials published in journals. Therefore, we explored the potential for
publication bias in randomized trials with active treatment, placebo, and no-treatment groups.
Methods: Three-armed randomized trials of acupuncture, acupoint stimulation, and transcutaneous electrical stimulation
were obtained from electronic databases. Effect sizes between treatment and placebo groups were calculated for treatment
effect, and effect sizes between placebo and no-treatment groups were calculated for placebo effect. All data were then
analyzed for publication bias.
Results: For the treatment effect, small trials with fewer than 100 patients per arm showed more benefits than large trials
with at least 100 patients per arm in acupuncture and acupoint stimulation. For the placebo effect, no differences were
found between large and small trials. Further analyses showed that the treatment effect in acupuncture and acupoint
stimulation may be subject to publication bias because study design and any known factors of heterogeneity were not
associated with the small study effects. In the simulation, the magnitude of the placebo effect was smaller than that
calculated after considering publication bias.
Conclusions: Randomized three-armed trials, which are necessary for estimating the placebo effect, may be subject to
publication bias. If the magnitude of the placebo effect is assessed in an intervention, the potential for publication bias
should be investigated using data related to the treatment effect.
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Introduction
The ‘‘powerful placebo’’ [1] was widely accepted until recently,
when consecutive reviews of the placebo effect were published [2–
4]. In these reviews, authors defined the placebo effect as the
difference in outcome measures between placebo and no-
treatment groups [5]. All possible randomized trials with three
arms (i.e., an active treatment group, a placebo group, and a no-
treatment group) were rigorously collected. The authors found
that although the effect varied from large to non-existent, the
placebo generally did not have a powerful impact in clinical
situations [4].
Because such conclusions were based on publicly reported
clinical trials, trials used for analysis should be unbiased. However,
there have been concerns over publication bias [6–10], where
small studies with negative results in an active group would be less
likely to be published. In a recent study on antidepressant agents
[11], 37 of 38 trials that were deemed positive by the Food and
Drug Administration of the United States were published in
journals, whereas only 3 of 36 trials with negative results were
published. In fact, 11 of 36 trials with negative results were
published in journals in a way that conveyed a positive outcome.
If three-armed trials that include placebo and no-treatment
groups are subject to publication bias, the conclusion for the
placebo effect might be misleading. To address the publication
bias in three-armed trials, we investigated two datasets on active
treatment versus placebo groups and placebo versus no-treatment
groups. Because acupuncture has been a hot-button issue in
discussions of the placebo effect [12,13], our study focuses on
acupuncture and its relevant interventions (i.e., acupoint stimula-
tion and transcutaneous electrical nerve stimulation (TENS)).
Methods
Search strategy
All trials were identified by searching randomized trials using
the search terms pertaining to each treatment via MEDLINE
(PubMed), EMBASE (or SCOPUS), and the Cochrane Central
Register of Controlled Trials from their inception through
October 2009. For example in PubMed, we used terms for
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for acupoint stimulation [‘‘acupressure’’ OR ‘‘acustimulation’’ OR
‘‘acupoint stimulation’’ OR ‘‘acupoint massage’’ OR ‘‘capsicum
plaster’’ OR ‘‘transcutaneous electrical stimulation’’ OR ‘‘func-
tional electrical stimulation’’], and terms for TENS [‘‘transcuta-
neous electrical stimulation’’ OR ‘‘transcutaneous electrical nerve
stimulation’’ OR ‘‘TENS’’], with limits to randomized controlled
trials and humans. We used EMBASE for acupuncture and
SCOPUS for the other two interventions because the availability
of EMBASE expired at Asan Medical Library during our search.
We defined acupoint simulation as any treatment that simulates
the traditional acupuncture points without penetrating human
skin.
Selection criteria
The titles and abstracts of all resulting papers were read by two
independent reviewers. However, those retrieved for TENS via the
Cochrane Central Register of Controlled Trials database were
read jointly. We then independently selected trials that included
the following: (1) a randomized clinical trial; (2) a group where an
intervention was pragmatically labeled as placebo; and (3)
comparison of treatment, placebo, and no-treatment groups under
identical conditions in one trial. However, we found only four [14–
17], four [18–21], and zero trials with binary outcomes for
acupuncture, acupoint stimulation, and TENS, respectively.
Because regression-based tests are reported to have low statistical
power for 10 or fewer trials [22], we decided to present the results
of trials with continuous outcomes.
Data extraction
Prior to data extraction, we prepared a protocol. First, we
attempted to select the main outcome that was considered primary
or was used for power calculation. When the above conditions
were not fulfilled, there were two methods we could choose: (1)
selecting the outcome on which the conclusion was based or (2)
choosing the outcome reported first in the table or figure. When
we examined the data of a previous report [4] using 31 eligible
trials that did not explicitly report the main outcome, the former
method resulted in 27 matches, whereas the latter resulted in 23
matches. Therefore, we extracted data using the former method.
Second, we attempted to extract end-point data, because 52
eligible trials reported end-point data, whereas only 15 reported
data on change from baseline. If such data were not available, the
data on change from baseline were used. Third, we attempted to
extract data evaluated at the end of the treatment, because most
trials reported data assessed at the end of the treatment. We (KYH
and WSR) then independently extracted data from eligible trials
and referenced the previous reviews [4,13] in open discussion.
When necessary, we contacted the corresponding authors of
included trials.
However, we met one problem in a trial [23] where standard
deviations could not be obtained. Because the outcome used in this
trial was unique within all eligible trials, we extracted data on the
outcome used in a previous report [4].
In addition, we (KYH and WSR) independently extracted
information on disease type and data type, as well as methodo-
logical characteristics (i.e., allocation concealment, assessor
blinding, attrition rate, and intention-to-treat analysis). Allocation
concealment was considered adequate if researchers responsible
for patient selection could not predict the next treatment for a
patient. Assessor blinding was considered adequate if outcome
measures of interest were evaluated by researchers blinded to the
treatment allocation or by objective instruments. Attrition rate was
considered adequate if the flow of the patients’ dropout
throughout the trial was explicitly stated, and the attrition rate
of all randomized patients who were assessed at baseline was below
15%. Intention-to-treat analysis was considered adequate if all
randomized patients who were assessed at baseline were included
in the analysis.
Data synthesis
In each trial, we calculated effect sizes (standardized mean
differences) between the active treatment and placebo groups and
between the placebo and no-treatment groups. The effect sizes
between active treatment and placebo groups were defined as
‘‘treatment effect’’ and those between placebo and no-treatment as
‘‘placebo effect’’. We excluded trials from the calculations that
reported only median and range because estimation from median
and range might produce bias [24]. Indeed, the effect size
calculated from median and range was overestimated in our
previous study [25]. We also excluded trials that were clear
outliers. To do this, we performed a test based on the blocked
adaptive computationally efficient outliers nominator algorithm
[26], with a significance level of 0.15.
Identification of small study effects
We used four methods to address small study effects, where the
smaller studies in a meta-analysis show larger treatment effects.
First, we considered trials with more than 200 patients at baseline
in two relevant arms as ‘‘large’’ trials and trials with fewer than
200 patients as ‘‘small’’ trials [27]. For example, when we
considered a trial where 300 patients were randomized to an
active treatment group (n=150), a placebo group (n=75), and a
no-treatment group (n=75), it was classified as a large trial for the
treatment effect and as a small trial for the placebo effect. We then
calculated the effect sizes of large and small trials separately using
a random effects model [28] and derived the differences between
the effect sizes of large and small trials. The p value was based on
an interaction test, which is defined as the difference in effect sizes
divided by the standard error of the difference [29]. For summary
estimates, we combined all differences between large and small
trials using a random effects model. Second, we drew a contour-
enhanced funnel plot [30]. In this study, a plot was divided into
areas of significance (two-sided P#0.05) and areas of non-
significance (two-sided P.0.05). Thirdly, we evaluated funnel
plot asymmetry using the asymmetry coefficient, which is defined
as the difference in effect size per standard error increase [31]. To
this end, we predicted a treatment or placebo effect from a
weighted linear regression with the standard error as an
independent variable. We then combined all asymmetry coeffi-
cients using a random effects model, crude and adjusted for
methodological characteristics, clinical condition (pain or non-
pain), and data type (subjective or objective outcome). Fourth, we
performed an Egger’s regression test [32].
Identification of sources of small study effects
When the small study effects were detected, we performed two
additional tests to exclude the other sources of small study effects
(i.e., quality of methodological design and true heterogeneity) [32].
In the first test, we categorized trials by methodological
characteristics and compared the pooled effect sizes between trials
with or without characteristics based on an interaction test. Even if
the small study effects were detected in only one treatment, we
decided to show all three treatments to maintain the internal
consistency of our study. In the second test, we investigated the
causes of heterogeneity by univariate meta-regression using the
following conditions: clinical conditions (pain or non-pain), disease
duration (acute or chronic), cointervention (present or none),
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treatment session.
Simulation
First, we estimated two different effect sizes for the treatment
and placebo effect in each intervention: (1) pooled effect sizes from
all identified trials and (2) effect sizes predicted at standard error
=0 for hypothetical trials of infinite size [31,33] from random
effects meta-regression analysis with the standard error as an
independent variable [27,32]. Second, we produced hypothetical
trials that could be suppressed by publication bias using a non-
parametric trim and fill analysis with a fixed effects model on
original data for the treatment effect [34]. We estimated effect
sizes for the treatment effect from identified trials and hypothetical
trials. In hypothetical trials, we then assumed that active treatment
was at least as effective as no-treatment. We added these trials to
the original data on placebo versus no-treatment and estimated
effect sizes for the placebo effect. Finally, we compared the three
effect sizes for the treatment and placebo effect.
Statistical analysis
For heterogeneity, we assessed the values of between-trial
variance (t
2). The data are presented as the mean with 95%
confidence interval. Microsoft Excel 2003 was used for interaction
tests and STATA version 11.0 for all further analyses.
Results
Figure 1 describes the procedure for selecting eligible trials. We
included 63 trials with continuous outcomes: 32 trials for
acupuncture (Text S1), 14 trials for acupoint stimulation (text
S2), and 17 trials for TENS (Text S3) (Table 1). Of these, the
overall number of large trials with more than 200 patients in two
relevant arms was small: 6 (18.8%) trials for treatment effect and 3
(9.4%) for placebo effect in acupuncture, 2 (11.8%) in TENS, and
none in acupoint stimulation. In total, 3060 patients were included
at baseline in the active treatment group, 2576 patients were
included in the placebo group, and 2533 patients were included in
the no-treatment group. In the eligible trials, many different
clinical conditions were assessed. Acupuncture and TENS trials
frequently studied pain-related disease, and acupoint stimulation
trials frequently investigated nausea-related disease. Placebo type
also varied within each intervention. Acupuncture needles that
were normally inserted or minimally inserted at irrelevant points
were commonly used as a placebo in acupuncture trials.
Stimulation on irrelevant points was mostly used as the placebo
in acupoint stimulation. Simulated TENS with electricity off was
mostly used as the placebo in TENS.
Of 63 eligible trials, 2 reported outcomes with median and
range: one [35] for acupuncture and another [36] for acupoint
stimulation. One trial [37] for TENS presented insufficient data
(e.g., no patient number). One trial [38] for TENS was a clear
outlier. Therefore, we excluded these trials from our analysis.
Within the remaining trials, the summary treatment effects were
0.41 (0.24 to 0.58), 0.64 (0.28 to 0.99), and 0.30 (0.11 to 0.49) for
acupuncture, acupoint stimulation, and TENS, respectively. The
summary placebo effects were 0.34 (0.19 to 0.49), 0.21 (0.07 to
0.35), and 0.05 (20.06 to 0.17), respectively. When heterogeneity
was compared between the treatment and placebo effects, the
placebo effects were less heterogeneous than the treatment effects
in all interventions.
When small and large trials were compared for treatment effect
(Figure 2), the difference in effect sizes between large and small
trials was statistically significant in acupuncture (P=0.009) and
acupoint stimulation (P=0.0005). For acupuncture, small trials
showed more benefits by 0.39 (0.10 to 0.68) in effect size than large
trials, and for acupoint stimulation, more benefits by 0.64 (0.28 to
0.99) in effect size. However, there was no significant difference
between small and large trials in TENS. The summary difference
of 20.37 (20.69 to 20.05) over the three interventions was
statistically significant. When small and large trials were compared
for placebo effect, a significant difference was found only in the
acupoint stimulation (P=0.004). The summary difference of
20.06 (20.25 to 0.13) was not statistically significant.
Figure 3 presents the funnel plots, where predicted treatment or
placebo effect lines (i.e., coefficient asymmetries) were included.
For the treatment effect in acupuncture and acupoint stimulation,
the left portion of the triangle was clearly missing when an
imaginary triangle was drawn with the lowest standard error as a
peak. In addition, the predicted treatment effect lines were not
upright (P=0.047 in acupuncture and P=0.006 in acupoint
stimulation) (Figure 3 and Table 2). However, the scatter plot of
effect sizes in TENS was clearly symmetrical, and the predicted
treatment effect line was upright (P=0.975). The summary
asymmetry coefficient was 2.48 (20.54 to 5.50). Even when the
summary asymmetry coefficient was adjusted for methodological
characteristics, clinical condition, and data type, it was still similar
to the crude value. For the placebo effect in the three
interventions, the scatter plots of the effect sizes were clearly
symmetrical and the predicted placebo effect lines were upright
(P=0.459, 0.638, and 0.683 for acupuncture, acupoint stimula-
tion, and TENS, respectively) (Figure 3 and Table 2). The
Figure 1. Study flow diagram.
doi:10.1371/journal.pone.0020679.g001
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did not differ after adjustment of methodological characteristics,
clinical condition, and data type.
Table 3 shows the results of Egger’s regression tests. For the
treatment effect, bias was present in acupuncture (P=0.012) and
acupoint stimulation (P=0.005), although no bias was found in
TENS (P=0.716). For the placebo effect, no significant bias was
found in any of the interventions (P=0.376, 0.607, and 0.665 for
acupuncture, acupoint stimulation, and TENS, respectively).
Table 4 presents the pooled treatment effects of three
interventions categorized by methodological characteristics. P
values for the interaction test did not show any significant
differences between trials in any of the three interventions. When
the causes of heterogeneity were examined, no factor was
associated with the effect sizes in acupuncture or acupoint
stimulation.
Figure 4 shows the results of the pooled effect sizes of all eligible
trials, the predicted effect sizes for hypothetical trials with infinite
Table 1. Characteristics of trials with continuous outcomes.
Acupuncture (n=32) Acupoint stimulation (n=14) TENS (n=17)
Number of large trials 6/3
* None 2
Total sample size
{ 2019/1601/1556 400/395/400 641/580/577
Clinical condition Pain: 17 Pain: 2 Pain: 16
Nausea: 1 Nausea: 6
Depression: 3 Insomnia: 2
Anxiety: 2 Others: 4
Others: 9
Placebo type Normal needling at irrelevant point: 11 No stimulation on relevant point: 2 TENS with no stimulation: 14
Minimal needling at irrelevant point: 16 Stimulation on irrelevant point: 12 TENS with sub-threshold stimulation: 1
No penetration: 2 TENS with non-segmental stimulation: 1
Others: 2
Treatment effect
Effect size (95% CI) 0.41 (0.24 to 0.58) 0.64 (0.28 to 0.99) 0.30 (0.11 to 0.49)
Heterogeneity t
2=0.16 t
2=0.34 t
2=0.06
Placebo effect
Effect size (95% CI) 0.34 (0.19 to 0.49) 0.21 (0.07 to 0.35) 0.05 (20.06 to 0.17)
Heterogeneity t
2=0.10 t
2=0.00 t
2=0.00
CI = confidence interval.
*The earlier value is for treatment effect, and the latter for placebo effect.
{Numbers are values for active treatment, placebo, and no-treatment groups, respectively.
doi:10.1371/journal.pone.0020679.t001
Figure 2. Difference in effect sizes between large trials with at least 100 patients per arm and small trials with fewer than 100
patients. ES = effect size.
doi:10.1371/journal.pone.0020679.g002
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trim and fill analysis. For the treatment effect (Figure 4A and B),
the effect sizes combined over eligible trials were greater than
those predicted for hypothetical trials with infinite size or those
simulated on data from nonparametric trim and fill analysis. For
the placebo effect (Figure 4A and B), the effect sizes combined over
eligible trials were smaller than those simulated on data from non-
parametric trim and fill analysis, although they were included
within the range of the 95% confidence interval for hypothetical
placebo effect from meta-regression with standard error =0.
Figure 3. Contour-enhanced funnel plot including predicted lines from univariable meta-regression models.
doi:10.1371/journal.pone.0020679.g003
Table 2. Asymmetry coefficients.
Treatment effect Placebo effect
Coefficient (95% CI) Coefficient (95% CI)
P value P value
Acupuncture 1.80 (0.02 to 3.58) 20.57 (22.20 to 1.06)
P=0.047 P=0.482
Acupoint stimulation 7.01 (2.52 to 11.49) 20.67 (23.74 to 2.39)
P=0.006 P=0.638
TENS 0.04 (22.44 to 2.52) 0.25 (21.03 to 1.53)
P=0.975 P=0.683
Summary coefficient 2.48 (20.54 to 5.50) 20.11 (20.99 to 0.78)
CI = confidence interval.
doi:10.1371/journal.pone.0020679.t002
Table 3. Egger’s regression tests.
Treatment effect Placebo effect
Coefficient (95% CI) Coefficient (95% CI)
P value P value
Acupuncture 1.99 (0.47 to 3.51) 20.64 (22.09 to 0.81)
P=0.012 P=0.376
Acupoint stimulation 6.84 (2.53 to 11.16) 20.67 (23.48 to 2.13)
P=0.005 P=0.607
TENS 0.34 (21.62 to 2.30) 0.25 (20.96 to 1.46)
P=0.716 P=0.665
CI = confidence interval.
doi:10.1371/journal.pone.0020679.t003
Placebo Effect and Publication Bias
PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e20679Discussion
In this study on three-armed trials for placebo effect, we found
that small trials showed a greater effect than large trials (i.e., small
study effects) when examining the treatment effect for acupuncture
and acupoint stimulation, defined by the effect size between active
and placebo groups. We did not find any such tendency in the
placebo effect for the three interventions, defined by the effect size
between placebo and no-treatment groups. In further analysis, the
small study effects in acupuncture and acupoint stimulation did
not appear to be related to trial methodology or true heteroge-
neity, thus indicating publication bias.
It is surprising that some three-armed trials may be published
according to the significance of an active treatment group. If trials
with a significantly greater effect of an active treatment compared
with a placebo are more likely to be published, the magnitude of
the placebo effect may be seriously biased. In fact, when the
missing trials were considered, the summary treatment effects for
acupuncture and acupoint stimulation decreased from those
combined over all eligible trials (Figure 4). In contrast, the
summary placebo effects for acupuncture and acupoint stimulation
increased from those pooled over all eligible trials (Figure 4).
Consequently, publication bias distorted the results of meta-
analyses based on identified trials for both effects.
However, it should be noted that the magnitude of the placebo
effect cannot be accurately predicted, because excellent statistical
analyses cannot predict missing trials accurately. In fact, a trim
and fill analysis using a random effects model detected no missing
trials in three interventions. Although missing trials are identified
by some analyses, the magnitude of placebo effect cannot be easily
conjectured. In the simulation, we assumed that active treatment
was at least as effective as no-treatment. However, this assumption
Table 4. Treatment effect of trials with or without methodological characteristics.
Acupuncture Acupoint stimulation TENS
Effect size (95% CI) P
* Effect size (95% CI) P
* Effect size (95% CI) P
*
Allocation concealment
Yes 0.28 (0.11 to 0.46) 0.16 0.94 (20.39 to 2.26) 0.59 0.11 (20.06 to 0.29) 0.06
No/unclear 0.55 (0.21 to 0.89) 0.56 (0.21 to 0.91) 0.41 (0.16 to 0.65)
Assessor blinding
Yes 0.42 (0.20 to 0.65) 0.90 0.72 (0.04 to 1.41) 0.75 0.19 (20.07 to 0.45) 0.29
No/unclear 0.40 (0.12 to 0.68) 0.59 (0.15 to 1.03) 0.39 (0.12 to 0.67)
Attrition rate
Good 0.42 (0.22 to 0.62) 0.94 0.47 (20.05 to 0.99) 0.39 0.11 (20.08 to 0.30) 0.09
Bad 0.40 (0.04 to 0.77) 0.78 (0.31 to 1.26) 0.37 (0.14 to 0.60)
Intention-to-treat analysis
Yes 0.30 (0.08 to 0.51) 0.14 1.32 (20.66 to 3.31) 0.44 0.12 (20.27 to 0.52) 0.36
No/unclear 0.56 (0.28 to 0.84) 0.53 (0.18 to 0.88) 0.33 (0.12 to 0.54)
CI = confidence interval.
*P values are based on interaction test.
doi:10.1371/journal.pone.0020679.t004
Figure 4. Results of effect sizes combined over all trials, effect sizes predicted for trials from random effects meta-regression
analysis with standard error =0, and effect sizes simulated on data from nonparametric trim and fill analysis. SE = standard error.
doi:10.1371/journal.pone.0020679.g004
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treatment may be superior to no-treatment in most situations [39],
the magnitude of the placebo effect will be much greater than that
predicted in the simulation. Therefore, we are not sure, at present,
whether the placebo effect from meta-regression with standard
error =0 can predict the placebo effect that was recalculated after
considering publication bias, although the former predicted the
latter in our simulation.
Previous reviews [2–4] have shown that placebos may not have
important clinical impacts in general. This finding led some
researchers to conclude that the concept of a ‘‘powerful placebo’’
remains groundless [40]. However, our finding implies that the
small overall placebo effect might be produced by publication bias.
Because publication bias is dependent on the significance of
treatment effect, trials published in journals are more likely to have
a relatively smaller placebo effect. If such trials are combined, the
overall placebo effect would be small.
Previous reviews [4,13] have also shown that when placebos
were examined in acupuncture trials with high quality, they were
associated with greater effect in some situations and with non-
existing effect in other situations. However, our finding implies
that the variable magnitude of the placebo effect may be
secondary to the natural process of publication. For example, if
one intervention is developed as a new therapy, trials with greater
effect of intervention begin to be published. At this time, the
heterogeneity of the placebo effect would be small. However, trials
with a smaller or negative effect will be published in the future. In
this case, the magnitude of the placebo effect begins to be variable.
To confirm this, we categorized acupuncture trials by publication
year. Interestingly, as time passed, the value of t
2 for the placebo
effect gradually increased from 0.00 to 0.10 with a shape of ,.
Previous reviews [2–4] have found that the placebo effect on
pain-related clinical conditions was great. We did not address this
point in our study, but we did address other questions regarding
whether methodological characteristics or some other factors were
associated with publication bias. We found that none were
associated with publication bias. However, we only investigated
three interventions. Furthermore, we could not extract diverse
factors from trials of each intervention (e.g., all TENS trials were
focused on pain-related conditions). Therefore, all interventions
should be investigated to determine whether certain factors are
associated with publication bias.
Although a previous review [4] and our study investigated the
placebo effect using the same criteria, interpretations were very
different. The discrepancies can be explained in several ways.
First, we analyzed many other trials, including the most recent
ones. We reviewed all randomized trials, even if the abstract was
not in the web databases. Surprisingly, this simple search strategy
yielded more trials than the updated review that used complex
search strategies aimed at detecting all three groups in one trial.
When trials published up to March 2008 were considered, we
consequently included seven more acupuncture trials [41–47], two
more acupoint stimulation trials [48,49], and four more TENS
trials [37,50–52] than the previous review.
Second, we investigated two datasets on the treatment and
placebo effects of each individual intervention. Using two datasets,
we attempted to study whether three-armed trials for the placebo
effect were biased. We found that the placebo effect should be
explored after examining the potential for bias on the treatment
effect. Meanwhile, the previous review studied only one dataset on
the placebo effect. The previous review also investigated the
potential for bias. However, our finding suggests that it is difficult
to find any bias in such early investigations of data related to the
placebo effect.
In our study, we attempted to prove publication bias. To this
end, we tried to review all randomized trials and thus included
many relevant three-armed trials. However, reviewing all
randomized trials is labor-intensive and time-consuming. Unfor-
tunately, we may have missed some relevant trials. In addition, we
did not use several potential sources to identify further trials. First,
we did not consult the existing relevant review [4]. When our
study was compared with the previous review [4], we found that
one trial [53] was not included in our study. Second, we did not
search the public trial registries, such as ClinicalTrials.gov (http://
www.clinicaltrials.gov/) or the International Standard Random-
ized Controlled Trial Number Web site (http://www.controlled-
trials.com/isrctn/). It is possible that three-armed trials might be
reported as two-armed trials in journals for many reasons (e.g.,
authors’ performance). Unless such trials explicitly report this
point, they cannot be easily identified without searching the
clinical trials registers. The failure to use means at our disposal to
identify additional trials represents a limitation of this study.
In this study, we did not fully address the issue of publication
bias. Because there are no definitive methods to evaluate
publication bias [54], we assessed small study effects and then
excluded two potential sources of small study effects (i.e., quality of
methodological design and true heterogeneity). However, some
researchers [55] may wonder whether the small study effects were
associated with real treatment effects. It is possible that patients at
high risk of disease in smaller trials could have received substantial
benefits from interventions. However, when we examined
acupuncture trials reporting pain intensity, patients with more
severe pain did not receive increased benefits (P=0.50). Other
researchers [32] may wonder whether interventions have been
implemented less thoroughly in larger trials, thus resulting in more
positive results than in smaller trials. When acupuncture trials
were considered as an example, this appeared to be unlikely
because relatively larger trials [56–58] utilized semi-individualized
treatments, whereas small trials [41,44–46] only utilized standard-
ized treatments.
We think that our findings have laid the groundwork for debate
on the use of placebos in clinical practice. Clinical evidence in
support of the placebo effect has been accumulated in a wide
range of conditions [59–63]. However, the evidence has been
discounted because it was derived from randomized trials that did
not include a no-treatment group [64]. In contrast, previous
reviews [2–4] addressing this defect argued that the placebo effect
was limited in general. We revealed that this argument might be
misleading. To sum up, the placebo effect appears to be a common
phenomenon. Therefore, ethical guidelines for the use of placebos
should be discussed [65]. We also think that our findings provide
different viewpoints on the placebo effect. Two previous reviews
[2,3] concluded that the greater placebo effect was associated with
pain-related clinical conditions, and a recent study [4] added that
physical placebo interventions were also associated. However,
according to our findings, the placebo effect for TENS was not
great in pain-related conditions. Therefore, our findings indicate
that analyzing the placebo effect as categorized by intervention is
also important.
Conclusions
Consequently, randomized three-armed trials necessary for
estimating the placebo effect were published in journals according
to the significance of an active treatment group in some
interventions. Publication bias distorted results for the placebo
effect in meta-analyses based soley on identified trials. Therefore, if
the magnitude of the placebo effect is being assessed in some
Placebo Effect and Publication Bias
PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e20679interventions, the potential for publication bias should be
investigated in data related to the treatment effect.
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